Stoke Therapeutics
STOK
STOK
96 hedge funds and large institutions have $372M invested in Stoke Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 34 increasing their positions, 40 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-11
Holders Change %
-10.28%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
5
Increased
34
Reduced
40
Closed
16
Calls
$120K
Puts
$14K
Net Calls
+$106K
Net Calls Change
-$36K
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
$34.5M |
| 2 |
CAC
Cowen and Company
New York
|
$27.3M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
$17.6M |
| 4 |
RI
RTW Investments
New York
|
$36.6M |
| 5 |
Morgan Stanley
New York
|
$24.4M |
